MINNEAPOLIS, MN--(Marketwire - October 29, 2008) - Virogen, Inc. (PINKSHEETS: VRGI), the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide, announced that due to the recent turmoil in the markets the company has made the decision to cancel the previously announced forward split indefinitely.
